Search Results - "Ippei Watanabe"

Refine Results
  1. 1

    Biochemical and crystallographic assessments of the effect of 4,6‐O‐disulfated disaccharide moieties in chondroitin sulfate E on chondroitinase ABC I activity by Watanabe, Ippei, Miyanaga, Akimasa, Hoshi, Hirotaka, Suzuki, Kiyoshi, Eguchi, Tadashi

    Published in The FEBS journal (01-05-2023)
    “…O‐sulfated N‐acetyl‐d‐galactosamine (GalNAc) residues in chondroitin sulfate (CS) play a crucial role in chondroitinase ABC I (cABC‐I) activity. CSA containing…”
    Get full text
    Journal Article
  2. 2

    Rheological and Adhesive Properties to Identify Cohesive and Dispersive Ophthalmic Viscosurgical Devices by Watanabe, Ippei, Hoshi, Hirotaka, Sato, Miwako, Suzuki, Kiyoshi

    Published in Chemical & pharmaceutical bulletin (01-03-2019)
    “…The purpose of this study is to evaluate the usefulness of the rheological properties and adhesive force of ophthalmic viscosurgical devices (OVDs) as…”
    Get full text
    Journal Article
  3. 3

    Contemporary Management of Stable Coronary Artery Disease ― Implications of the ISCHEMIA Trial by Kohsaka, Shun, Fukushima, Kenji, Watanabe, Ippei, Manabe, Susumu, Niimi, Nozomi, Gatate, Yodo, Sawano, Mitsuaki, Nakano, Shintaro

    Published in Circulation Journal (25-10-2021)
    “…Coronary artery disease (CAD) remains a leading cause of mortality and morbidity in developed countries. Although urgent revascularization is the cornerstone…”
    Get full text
    Journal Article
  4. 4

    Advances in Understanding the Mechanism of Ophthalmic Viscosurgical Device Retention in the Anterior Chamber or on the Corneal Surface during Ocular Surgery by Watanabe, Ippei, Yoshioka, Keiji, Takahashi, Katsuya, Hoshi, Hirotaka, Nagata, Mayumi, Matsushima, Hiroyuki, Suzuki, Kiyoshi

    Published in Chemical & pharmaceutical bulletin (01-06-2021)
    “…Retention durability, especially in the eye, is one of the most important properties of ophthalmic viscosurgical devices (OVDs) during ocular surgery. However,…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Injectable in situ cross-linking hyaluronan hydrogel for easier removal of posterior vitreous cortex in vitrectomy by Hisatomi, Toshio, Tachibana, Takashi, Mori, Kenichiro, Ishikawa, Keijiro, Ishibashi, Tatsuro, Sonoda, Koh-Hei, Uchio, Eiichi, Watanabe, Ippei, Suzuki, Kiyoshi, Iida, Masami

    Published in Japanese journal of ophthalmology (01-03-2024)
    “…Purpose Removing transparent vitreous tissues, such as a residual vitreous cortex (VC) or proliferative membrane, without damaging the retina is often…”
    Get full text
    Journal Article
  7. 7

    Histological analysis of nucleus pulposus tissue from patients with lumbar disc herniation after condoliase administration by Minamisawa, Yuka, Shirogane, Taiichi, Watanabe, Ippei, Dezawa, Akira

    Published in JOR-spine (01-06-2024)
    “…Background Condoliase is an enzyme used as a treatment for lumbar disc herniation (LDH). This enzyme degrades chondroitin sulfate (CS) in the nucleus pulposus…”
    Get full text
    Journal Article
  8. 8

    Development of in situ crosslinked hyaluronan as an adjunct to vitrectomy surgery by Suzuki, Kiyoshi, Watanabe, Ippei, Tachibana, Takashi, Mori, Kenichiro, Ishikawa, Keijiro, Ishibashi, Tatsuro, Uchio, Eiichi, Sonoda, Koh-Hei, Hisatomi, Toshio

    “…Ophthalmologists have used hyaluronan (HA) products as adjuncts to ocular surgery since the 1970s. However, HA products are not always functional in surgeries…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Heart Rate After Resuscitation From Out-of-Hospital Cardiac Arrest due to Acute Coronary Syndrome Is an Independent Predictor of Clinical Outcome by Matsumoto, Shingo, Nakanishi, Rine, Watanabe, Ippei, Aikawa, Hiroto, Noike, Ryota, Yabe, Takayuki, Okubo, Ryo, Fujino, Tadashi, Amano, Hideo, Toda, Mikihito, Ikeda, Takanori

    Published in Circulation Journal (25-03-2020)
    “…Background:Heart rate (HR) is a useful predictor of cardiovascular disease, especially in acute coronary syndrome (ACS). However, it is unclear whether there…”
    Get full text
    Journal Article
  11. 11

    Molecular Hydrogen Alleviates Cellular Senescence in Endothelial Cells by Hara, Fumihiko, Tatebe, Junko, Watanabe, Ippei, Yamazaki, Junichi, Ikeda, Takanori, Morita, Toshisuke

    Published in Circulation Journal (25-08-2016)
    “…Background:Substantial evidence indicates that molecular hydrogen (H2) has beneficial vascular effects because of its antioxidant and/or anti-inflammatory…”
    Get full text
    Journal Article
  12. 12

    Frailty and coronary plaque characteristics on optical coherence tomography by Amano, Hideo, Noike, Ryota, Yabe, Takayuki, Watanabe, Ippei, Okubo, Ryo, Koizumi, Masayuki, Toda, Mikihito, Ikeda, Takanori

    Published in Heart and vessels (01-06-2020)
    “…The relationship between frailty and plaque characteristics is unclear and was investigated by optical coherence tomography (OCT) in this study. One hundred…”
    Get full text
    Journal Article
  13. 13

    Aryl Hydrocarbon Receptor Mediates Indoxyl Sulfate-Induced Cellular Senescence in Human Umbilical Vein Endothelial Cells by Koizumi, Masayuki, Tatebe, Junko, Watanabe, Ippei, Yamazaki, Junichi, Ikeda, Takanori, Morita, Toshisuke

    Published in Journal of Atherosclerosis and Thrombosis (01-01-2014)
    “…Aim: Vascular senescence, which is accelerated in individuals with chronic kidney disease (CKD), contributes to the development of cardio-renal syndrome, and…”
    Get full text
    Journal Article
  14. 14

    Activation of Aryl Hydrocarbon Receptor Mediates Indoxyl Sulfate-Induced Monocyte Chemoattractant Protein-1 Expression in Human Umbilical Vein Endothelial Cells by Watanabe, Ippei, Tatebe, Junko, Namba, Shunji, Koizumi, Masayuki, Yamazaki, Junichi, Morita, Toshisuke

    Published in Circulation Journal (2013)
    “…Background: Indoxyl sulfate (IS) is a uremic toxin that causes renal injury, but little is known about its adverse effects on the cardiovascular system. The…”
    Get full text
    Journal Article
  15. 15

    Association between coronary artery calcium score on non-contrast chest computed tomography and all-cause mortality among patients with congestive heart failure by Ota, Kyoko, Nakanishi, Rine, Hashimoto, Hidenobu, Okamura, Yuriko, Watanabe, Ippei, Yabe, Takayuki, Okubo, Ryo, Ikeda, Takanori

    Published in Heart and vessels (01-02-2022)
    “…Coronary artery calcium (CAC) score is a robust prognostic tool to predict cardiac events. Although patients with congestive heart failure (CHF) occasionally…”
    Get full text
    Journal Article
  16. 16

    D-sorbitol can keep the viscosity of dispersive ophthalmic viscosurgical device at room temperature for long term by Nogami, Eiji, Watanabe, Ippei, Hoshi, Hirotaka, Kasahara, Masakazu, Honda, Naoto, Sato, Miwako, Suzuki, Kiyoshi

    Published in Scientific reports (14-11-2019)
    “…The combination of 3% sodium hyaluronate (HA) and 4% sodium chondroitin sulfate (CS) is used as a dispersive ophthalmic viscosurgical device (OVD) during…”
    Get full text
    Journal Article
  17. 17

    Effect of contrast media on the enzyme activity of condoliase: In vitro assessment by Watanabe, Ippei, Shirogane, Taiichi, Matsuyama, Yukihiro, Chiba, Kazuhiro

    Published in JOR-spine (01-09-2022)
    “…Background Condoliase has been used in Japan to treat patients with lumbar disc herniation by its injection into the nucleus pulposus. The injection of…”
    Get full text
    Journal Article
  18. 18

    Plaque characteristics and slow flow during percutaneous coronary intervention of irregular protrusion by optical coherence tomography by Amano, Hideo, Noike, Ryota, Saito, Daiga, Yabe, Takayuki, Watanabe, Ippei, Okubo, Ryo, Koizumi, Masayuki, Toda, Mikihito, Ikeda, Takanori

    Published in Heart and vessels (01-07-2019)
    “…Irregular protrusion on optical coherence tomography (OCT) is associated with clinical events and target lesion revascularization. We investigated clinical and…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Comparing the effects of milrinone and olprinone in patients with congestive heart failure by Dobashi, Shintaro, Watanabe, Ippei, Nakanishi, Rine, Hisatake, Shinji, Kiuchi, Shunsuke, Kabuki, Takayuki, Oka, Takashi, Fujii, Takahiro, Ikeda, Takanori

    Published in Heart and vessels (01-06-2020)
    “…Phosphodiesterase-3 (PDE3) inhibitors are widely used among patients with congestive heart failure (CHF). However, no studies have compared the cardiovascular…”
    Get full text
    Journal Article